Cargando…

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies

BACKGROUND: Risk-prediction models have been proposed to select individuals for lung cancer screening. However, their long-term effects are uncertain. This study evaluates long-term benefits and harms of risk-based screening compared with current United States Preventive Services Task Force (USPSTF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Haaf, Kevin, Bastani, Mehrad, Cao, Pianpian, Jeon, Jihyoun, Toumazis, Iakovos, Han, Summer S, Plevritis, Sylvia K, Blom, Erik F, Kong, Chung Yin, Tammemägi, Martin C, Feuer, Eric J, Meza, Rafael, de Koning, Harry J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225672/ https://www.ncbi.nlm.nih.gov/pubmed/31566216 http://dx.doi.org/10.1093/jnci/djz164

Ejemplares similares

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial
por: Tammemägi, Martin C., et al.
Publicado: (2019)

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
por: ten Haaf, Kevin, et al.
Publicado: (2017)

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
por: ten Haaf, Kevin, et al.
Publicado: (2020)

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker
por: Toumazis, Iakovos, et al.
Publicado: (2021)

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling
por: McMahon, Pamela M., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings
por: Toumazis, Iakovos, et al.
Publicado: (2019)

Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study
por: Cao, Pianpian, et al.
Publicado: (2022)

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges
por: ten Haaf, Kevin, et al.
Publicado: (2021)

Treatment capacity required for full‐scale implementation of lung cancer screening in the United States
por: Blom, Erik F., et al.
Publicado: (2019)

Trends in US Adult Smoking Prevalence, 2011 to 2022
por: Meza, Rafael, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer
por: Blom, Erik F., et al.
Publicado: (2020)

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
por: Blom, Erik F, et al.
Publicado: (2020)

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility
por: Maki, Kristin G., et al.
Publicado: (2022)

Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting
por: Cao, Pianpian, et al.
Publicado: (2022)

Smoking Disparities by Level of Educational Attainment and Birth Cohort in the U.S.
por: Cao, Pianpian, et al.
Publicado: (2023)

Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021
por: Maki, Kristin G., et al.
Publicado: (2023)

Implementation of lung cancer screening: what are the main issues?
por: van der Aalst, Carlijn M., et al.
Publicado: (2021)

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
por: ten Haaf, Kevin, et al.
Publicado: (2017)

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
por: Aredo, Jacqueline V, et al.
Publicado: (2022)

Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol
por: Tam, Jamie, et al.
Publicado: (2018)

Cross-sectional Patterns and Longitudinal Transitions of Premium and Non-Premium Cigar Use in the United States
por: Jeon, Jihyoun, et al.
Publicado: (2023)

Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
por: Braithwaite, Dejana, et al.
Publicado: (2022)

Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
por: Mok, Yoonseo, et al.
Publicado: (2022)

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
por: Moolgavkar, Suresh H., et al.
Publicado: (2012)

Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer
por: Toumazis, Iakovos, et al.
Publicado: (2017)

Number and Size Distribution of Colorectal Adenomas under the Multistage Clonal Expansion Model of Cancer
por: Dewanji, Anup, et al.
Publicado: (2011)

Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
por: Meza, Rafael, et al.
Publicado: (2015)

Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
por: Choi, Eunji, et al.
Publicado: (2023)

Prediction of COPD risk accounting for time-varying smoking exposures
por: Chang, Joanne T., et al.
Publicado: (2021)

Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019
por: Phung, Minh Tung, et al.
Publicado: (2023)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients
por: Meza, Rafael, et al.
Publicado: (2022)

Development and Validation of a Personalized, Web-Based Decision Aid for Lung Cancer Screening Using Mixed Methods: A Study Protocol
por: Lau, Yan Kwan, et al.
Publicado: (2014)

Contemporary issues in the implementation of lung cancer screening
por: Lam, Stephen, et al.
Publicado: (2021)

A predictive model for lung cancer screening nonadherence in a community setting health-care network
por: Bastani, Mehrad, et al.
Publicado: (2023)

Comparison of Cholangiocarcinoma and Hepatocellular Carcinoma Incidence Trends from 1993 to 2012 in Lampang, Thailand
por: Cao, Pianpian, et al.
Publicado: (2022)

Public health implications of vaping in the USA: the smoking and vaping simulation model
por: Levy, David T., et al.
Publicado: (2021)

Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100
por: Tam, Jamie, et al.
Publicado: (2021)

A Multiscale Model Evaluates Screening for Neoplasia in Barrett’s Esophagus
por: Curtius, Kit, et al.
Publicado: (2015)

The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use
por: Brouwer, Andrew F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ntn9fnfr4rvf8tk00f12pj0bkr